SuperCrowd
Amendment · Form C/A
An amendment to an offering — the company changed its terms or corrected its filing.
iMetabolic Biopharma Corp
imbiopharma.com · NV · Filed Dec 28, 2022
iMetabolic Biopharma Corp filed a Form C/A — amendment — with the SEC on Dec 28, 2022. The Regulation Crowdfunding offering seeks $10,000, up to a maximum of $1,230,000 on StartEngine. Investors receive: Other. The offering closes 03-16-2023.
| Target raise | $10,000 |
|---|---|
| Maximum raise | $1,230,000 |
| Security | Other |
| Closes | 03-16-2023 |
| Portal | StartEngine |
Filing documents
offeringmemoformc.pdf
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.